Virdin 150 mg (Tablet)
Unit Price: ৳ 2.00 (100's pack: ৳ 200.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Virgo pharmaceuticals ltd |
Title
- Virdin Medicine Product
Categories
- Medicine
- Pharmaceuticals
- Healthcare
Description
- Ranitidine competitively blocks histamine at H2-receptors of the gastric parietal cells
- Virdin is indicated for the treatment of active duodenal ulcer, benign gastric ulcer, Zollinger-Ellison Syndrome, GERD, and more
- Dosage & Administration instructions for tablets, syrup, IV injection & infusion
- Interaction with propantheline bromide and effects on drug absorption
- Contraindications for patients hypersensitive to Ranitidine
- Side Effects include altered bowel habit, dizziness, rash, tiredness, and more
- Pregnancy & Lactation precautions for the use of Ranitidine
- Precautions & Warnings for patients with impaired renal and hepatic function
- Use in Special Populations such as elderly patients
- Overdose Effects and treatment options
- Therapeutic Class as H2 receptor antagonist
- Reconstitution instructions for IV administration
- Storage Conditions recommendation to store in a cool and dry place
Size
- Various dosages available including 150 mg and 300 mg
- Different package sizes for tablets and syrups
Color Options
- White tablets
- Clear syrup
Dosage Forms
- Tablets
- Syrup
- IV Injection
- IV Infusion
Ingredients
- Ranitidine
- Propantheline bromide
Technical Specifications
- Specific action of Virdin on H2-receptors blocking histamine
- Details on absorption rates and peak serum concentrations
Design Elements
- Medical packaging design
- Dosage instructions clearly labeled on packaging
Usability Features
- Ease of administration with different dosage forms
- Clear instructions for healthcare professionals
Materials
- Active ingredient: Ranitidine
- Dosage forms made of pharmaceutical-grade materials
Functionality
- Inhibition of gastric acid secretion
- Treatment of various gastrointestinal conditions
Warnings
- Caution for patients with impaired renal and hepatic function
- Not recommended for patients hypersensitive to Ranitidine
Age Group
- Suitable for adults
- Dosage adjustments needed for children based on weight
Special Precautions
- Reduced dosage for elderly patients
- Monitoring required for patients with renal or hepatic impairment
Package Content
- Number of tablets or ml of syrup per pack
- Contraindications and warnings leaflet included
Administration Route
- Oral for tablets and syrup
- Intravenous for injections and infusions
Side Effects Monitoring
- Monitoring for altered bowel habit, dizziness, and other reported side effects
Duration of Treatment
- Treatment duration ranges from 4 to 8 weeks depending on the condition
Allergic Reactions
- Monitoring for allergic reactions in hypersensitive patients
Storage Instructions
- Recommended storage in a cool and dry place away from light
Manufacturer
- Details about the pharmaceutical company producing Virdin
Certifications
- Compliance with pharmaceutical regulations and standards
- Quality certifications for manufacturing processes
Medical Advice
- Dosage adjustments based on individual patient conditions and responses
Consultation
- Recommendation to consult healthcare professionals before use
Nutritional Guidance
- No specific nutritional requirements associated with Virdin usage
Batch Number
- Identification code for tracking individual batches of Virdin products
Expiry Date
- Expiration date printed on packaging for product safety
Product Information
- User-friendly information leaflet inside the package
Dosage Adjustment
- Adjustments needed in cases of renal or hepatic impairment
Adverse Effects Monitoring
- Regular monitoring for possible adverse effects during treatment
Refill Instructions
- Instructions for refilling prescriptions as needed
Patient Counseling
- Counseling services for patients regarding medication usage and potential effects
Environmental Impact
- Details on environmental impact of product disposal
Labeling Information
- Clear labeling for dosage and administration instructions
Emergency Protocol
- Guidelines for emergency situations and overdose scenarios
Secondary Packaging
- Outer packaging for additional protection and information display
Drug Interactions
- Information on potential interactions with other medications
Medical Guidelines
- Compliance with medical guidelines for the treatment of specific conditions
Safety Precautions
- Instructions for safe handling and administration by healthcare professionals
Research Studies
- Results from research studies on the effectiveness of Virdin for different indications
Consultation Hours
- Availability of healthcare professionals for consultation on Virdin usage
Patient Follow-up
- Recommendation for patient follow-up visits during treatment
Prescription Information
- Guidelines on prescription requirements for Virdin
Health Monitoring
- Monitoring parameters for the assessment of treatment effectiveness
Drug Regulatory Authority
- Details on approval and regulation by drug regulatory authorities
Usage Restrictions
- Specific restrictions on usage for certain patient groups or conditions
Patient Education
- Educational resources for patients regarding their treatment with Virdin